Should you own shares of MannKind Corporation (MNKD) on Monday morning?
MannKind Corporation (MNKD) fell on Monday morning as the stock fell -19.25% in pre-market trading to 4.11. MNKD’s short-term technical score of 58 indicates that the stock has traded more bullish over the past month than 58% of the stock in the market. In the biotech industry, which ranks 139 out of 146 industries, stock ranks above 88% of stocks. MannKind Corporation rose 12.36% over the past month, closing at $ 4.48 on September 20. During that time, the stock fell to $ 4.35 and $ 5.44. MNKD has an average analyst recommendation from Strong Buy. The company has an average price target of $ 5.80.
MannKind Corporation has a long-term technical rank of 81. This means that trading in the last 200 trading days has placed the company in the top half of stocks with 19% of the market scoring higher. In the biotech industry which is number 135 by this metric, MNKD ranks better than 92% of stocks.
Important dates for investors in MNKD:
-MannKind Corporation is expected to release its results on 11/09/2021. When its results were last released, the company posted EPS of $ -0.36. – We do not have a fixed dividend date for MannKind Corporation at this time. Click here for the full report on MannKind Corporation (MNKD)